MedTrace Logo

Electric Blower Based Ventilator Used During Procedural Sedation

NCT02621463 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2021-04-27

Study results available
· View outcomes & findings →

Summary

Conduct human trials in the endoscopy suite of our continuous positive airway pressure (CPAP) ventilator approach using an FDA approved ventilator.

Conditions

  • Apnea During Procedural Sedation

Interventions

DEVICE

Noninvasive Ventilator (V60, Philips)

The clinician will determine the concentration of oxygen that shall be delivered to the patient. The ventilator is capable of providing concentrations between 21% - 100% of oxygen. Unless otherwise directed by the clinician, the default setting of 40% will be used.

Sponsors & Collaborators

  • National Aeronautics and Space Administration (NASA)

    collaborator FED

  • University of Utah

    lead OTHER

Principal Investigators

  • Kai Kuck, Ph.D. · University of Utah

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-01
Primary Completion
2019-06-01
Completion
2019-06-01

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02621463 on ClinicalTrials.gov